[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"fda-events-search:[\"\",\"\",\"PZL\",\"1990-01-01\",\"2026-11-22\",1]":3,"fda-latest-sync-dates":42},{"events":4,"total":41},[5,28],{"mdr_report_key":6,"report_number":7,"event_type":8,"date_received":9,"date_of_event":10,"report_source_code":11,"adverse_event_flag":12,"product_problem_flag":13,"product_problems":14,"brand_name":17,"generic_name":18,"product_code":19,"manufacturer_name":20,"model_number":21,"patient_outcomes":22,"remedial_action":24,"created_at":26,"updated_at":27},"50084120","3005462245-2026-00001","Injury","2026-07-30","2026-02-04","Manufacturer report","Y","N",[15,16],"Inappropriate\u002FInadequate Shock\u002FStimulation","Patient Device Interaction Problem","SOFTWAVE (name which patient reported) - correct: SOFTWAVE GOLD-LI","EXTRACORPOREAL SHOCK WAVE DEVICE  FOR TREATMENT OF DIABETIC FOOT ULCER","PZL","MTS Medical AG","OW100S-US",[23],"Other",[25],"","2026-08-19T02:28:57.543257+00:00","2026-08-19T02:36:34.534299+00:00",{"mdr_report_key":29,"report_number":30,"event_type":8,"date_received":31,"date_of_event":10,"report_source_code":32,"adverse_event_flag":12,"product_problem_flag":13,"product_problems":33,"brand_name":34,"generic_name":35,"product_code":19,"manufacturer_name":36,"model_number":21,"patient_outcomes":37,"remedial_action":39,"created_at":40,"updated_at":40},"25737625","MW5190361","2026-07-07","Voluntary report",null,"SOFTWAVE","EXTRACORPOREAL SHOCK WAVE DEVICE FOR TREATMENT OF DIABETIC FOOT ULCERS","MTS MEDICAL AG\u002FSOFTWAVE TISSUE REGENERATON TECHNOLOGIES, LLC",[38],"Disability",[25],"2026-09-07T05:15:06.704199+00:00",2,{"510k":43,"classification":44,"enforcement":45,"event":46,"event_backfill":47,"pma":48,"warning_letter":49},"2026-11-16T02:00:55.89+00:00","2026-11-16T02:00:41.999+00:00","2026-11-16T02:00:49.415+00:00","2026-11-22T04:00:36.543+00:00","2026-09-07T05:17:28.839+00:00","2026-11-16T02:01:03.155+00:00","2026-11-17T01:02:55.859+00:00"]